According to a new market report published by Lucintel, the future of the microbiome sequencing market looks promising with opportunities in drug discovery, genetic screening, disease diagnosis research, and personalized medicine. The global microbiome sequencing market is expected to grow with a CAGR of 18% from 2020 to 2025. The major drivers for this market are increasing focus on human microbiome therapy, rising government initiatives for microbiome research, and growing research activities for early disease diagnosis.
To download report brochure, please go to https://www.lucintel.com/microbiome-sequencing-service-market.aspx and click "download brochure" tab from the menu
Microbiome sequencing helps in studying microflora of human biota for understanding human microbes and role played by them in health and disease. In this market, sanger sequencing, high-throughput sequencing, and third-generation sequencing are the major sequencing technologies. Lucintel forecasts that sanger sequencing will remain the largest sequencing technology segment over the forecast period, as it is preferred more by researchers because of higher accuracy than other technologies.
Within this market, pharmaceutical and biotechnology companies will remain the largest end user segment over the forecast period due to increasing prevalnce of cancer and increasing demand for personlized genomics.
North America will remain the largest region over the forecast period due to rising research activies related to genomics, surge in number of research studies on cancer & inherited rare diseases, and increasing government support related to microbiome sequencing in the region.
Thermo Fisher Scientific, Illumina, Qiagen, Molzym, Novogene, Allele, Baseclear, BGI, Biolog, and Biomathematica are among the major suppliers in the global microbiome sequencing market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global microbiome sequencing market by sequencing technology, component, laboratory type, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Microbiome Sequencing Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global microbiome sequencing market by sequencing technology, component, laboratory type, application, end user, and region as follows:
By Sequencing Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Sanger Sequencing
High-throughput Sequencing
Sequencing by Synthesis (SBS)
Sequencing by Ligation (SBL)
Shotgun Sequencing
Targeted Gene Sequencing (TGS)
RNA (Ribonucleic Acid) Sequencing
Whole Genome Sequencing (WGS)
Others
Third-Generation Sequencing
By Component [Value ($ Million) shipment analysis for 2014 – 2025]:
Reagents and Kits
Instruments
Liquid Handling Instruments
Cytometers
Imaging Devices
Microplate Reader
By Laboratory Type [Value ($ Million) shipment analysis for 2014 – 2025]:
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Drug Discovery
Genetic Screening
Disease Diagnosis Research
Personalized Medicine
Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceutical and Biotechnology
Academic Centers and Research Institutes
Contract Research Organizations
Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.